What are the recommended postoperative care, follow‑up schedule, and monitoring—including levothyroxine replacement, calcium management, wound inspection, voice assessment, and laboratory testing—after a total or hemithyroidectomy?

Post-Surgical Care, Follow-Up, and Monitoring After Thyroidectomy

All patients undergoing thyroidectomy require systematic voice assessment between 2 weeks and 2 months postoperatively, with immediate senior surgical review for any signs of hematoma, and levothyroxine replacement initiated within 5 days for total thyroidectomy patients starting at 1.6 mcg/kg/day for adults. 1, 2, 3

Immediate Postoperative Monitoring (First 24-48 Hours)

Hematoma Surveillance

• Minimum monitoring includes wound inspection, early warning scoring, pain assessment, and vigilance for subtle signs including agitation, anxiety, breathing difficulty, or discomfort. 1
• A post-thyroid surgery emergency box must be available at bedside during the entire postoperative period, including during transfers. 1
• Emergency front-of-neck airway equipment (scalpel, bougie, tracheal tube) must be readily accessible on wards caring for post-thyroidectomy patients. 1
• If hematoma is suspected with airway compromise, use the SCOOP approach at bedside: Skin exposure; Cut sutures; Open skin; Open muscles (superficial and deep layers); Pack wound. 1
• Immediate senior surgical review (registrar or consultant level) is mandatory for any concern about potential hematoma; if unavailable or airway compromise exists, inform senior anesthesiologist immediately. 1

Calcium and Parathyroid Function Monitoring

• Measure parathyroid hormone (PTH) within 4 hours of surgery to identify patients at risk for symptomatic hypocalcemia. 4
• Patients with PTH <10 pg/mL require prophylactic treatment with calcitriol 0.25 mcg twice daily plus calcium carbonate 2-6 g daily for one week. 4
• A relative PTH decrease >70% from preoperative baseline is a significant risk factor for symptomatic hypocalcemia (sensitivity 72.1%, specificity 75%). 5
• For patients with relative PTH decrease >70% and postoperative day 1 PTH <1 pmol/L, calcitriol supplementation is indicated; longer hospitalization beyond postoperative day 1 is advocated for this group. 5
• Patients with PTH ≥10 pg/mL can be treated with calcium supplementation alone. 4

Voice Assessment Protocol

Timing and Documentation

• Document whether voice change has occurred between 2 weeks and 2 months following thyroid surgery. 1
• Any voice change persisting beyond 2 weeks should trigger formal otolaryngologic evaluation. 6
• Patients should report breathiness, hoarseness, reduced exercise tolerance, or increased vocal effort continuing beyond 2 weeks. 6

Evaluation of Voice Changes

• Examine vocal fold mobility or refer for examination in all patients with voice change following thyroid surgery. 1
• Refer patients to an otolaryngologist when abnormal vocal fold mobility is identified after thyroid surgery. 1
• Counsel patients with voice change or abnormal vocal fold mobility on options for voice rehabilitation. 1
• Early intervention with voice therapy between 2 weeks and 2 months postoperatively maximizes favorable long-term outcomes. 6

Clinical Context

• Approximately 10% of patients experience temporary laryngeal nerve injury, with persistent voice problems in up to 4% (1 in 25 patients). 1, 6
• Unilateral recurrent laryngeal nerve injury produces breathy voice, hoarseness, vocal fatigue, mild dysphagia, and visible vocal fold bowing. 6
• External branch of superior laryngeal nerve injury causes vocal fatigue worsening with prolonged speaking, reduced pitch elevation ability, impaired voice projection, and monotone speech. 6

Levothyroxine Replacement Therapy

Initiation Timing and Dosing

• Begin levothyroxine 5 days after surgery for patients requiring replacement. 3
• For total thyroidectomy in previously euthyroid adults: start 1.6 mcg/kg/day (approximately 150 mcg daily for average adults). 2, 3
• For subtotal thyroidectomy in previously euthyroid patients: start 100 mcg daily. 3
• For hemithyroidectomy in previously euthyroid patients: start 50 mcg daily. 3
• For total thyroidectomy in previously hyperthyroid patients: start 100 mcg daily. 3
• For subtotal thyroidectomy in previously hyperthyroid patients: start 50 mcg daily. 3

Administration Instructions

• Take as a single dose on an empty stomach, one-half to one hour before breakfast with a full glass of water. 2
• Avoid taking within 4 hours of iron supplements, calcium supplements, or antacids, which decrease absorption. 2

Monitoring Schedule

• Measure serum TSH 6-8 weeks after initiating therapy or any dose change. 2
• For patients on stable replacement: evaluate clinical and biochemical response every 6-12 months and whenever clinical status changes. 2
• The general aim is to normalize serum TSH within the reference range (typically 0.5-2.0 mIU/L for low-risk patients). 1

Special Considerations After Hemithyroidectomy

• Approximately one-third of patients develop hypothyroidism requiring levothyroxine within 3 years after hemithyroidectomy when TSH up to 4.0 mIU/L is accepted. 7
• The prevalence of endogenous normal thyroid function decreases progressively: 80% at 1 year, 69% at 2 years, and 66% at 3 years. 7
• Overall pooled incidence of hypothyroidism after hemithyroidectomy is 29%, with 23% requiring thyroxine supplementation. 8
• Risk factors for post-hemithyroidectomy hypothyroidism include: preoperative TSH ≥2 mIU/L (relative risk 2.87), female sex (RR 1.19), right-sided hemithyroidectomy (RR 1.35), presence of anti-TPO antibodies (RR 1.92), anti-Tg antibodies (RR 1.53), and Hashimoto's thyroiditis (RR 2.05). 8

Thyroid Cancer-Specific Follow-Up

Risk Stratification and TSH Targets

• For low-risk differentiated thyroid cancer after total thyroidectomy: maintain TSH 0.5-2.0 mIU/L. 1
• For intermediate-risk disease with excellent treatment response: maintain TSH 0.5-2.0 mIU/L. 1
• For biochemical incomplete response: maintain TSH 0.1-0.5 mIU/L. 1
• For structural incomplete response requiring treatment: maintain TSH <0.1 mIU/L. 1

Thyroglobulin and Imaging Surveillance

• Measure serum thyroglobulin (Tg) and thyroglobulin antibodies (TgAb) every 12-24 months for patients with excellent response. 1
• For biochemical incomplete response: measure Tg and TgAb every 6-12 months. 1
• For structural incomplete response: measure Tg and TgAb every 3-6 months. 1
• Neck ultrasound every 6-12 months for patients with structural disease; optional repeat after 3-5 years for those with excellent response. 1
• Short serum Tg doubling time (<1 year) is associated with poor outcomes and should prompt imaging staging. 1

Common Pitfalls and Caveats

Calcium Management

• This protocol using early PTH testing and prophylactic calcitriol reduces symptomatic hypocalcemia from 17% to 7% and emergency room visits from 8% to 1.8%. 4
• Symptomatic hypocalcemia remains the most common complication of total thyroidectomy and can lead to emergency presentations if not properly managed. 4

Levothyroxine Dosing

• Approximately 45% of previously euthyroid patients after total thyroidectomy and 42% after subtotal thyroidectomy require dose adjustments at 6 weeks. 3
• Previously hyperthyroid patients have higher rates of dose adjustment needs: 60% after total thyroidectomy and 100% after subtotal thyroidectomy. 3
• Patients should be informed that several weeks may pass before symptom improvement is noticed. 2

Voice Outcomes

• Non-neural causes of voice change include direct cricothyroid muscle injury, regional soft-tissue injury (scar, strap-muscle denervation, hematoma/edema), and intubation-related injury (vocal fold edema, hematoma, laceration, granuloma, arytenoid dislocation). 6
• Early postoperative vocal fold motion abnormalities may persist up to 4 weeks before formal evaluation is warranted. 6